Capital World Investors’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1,057,000	Closed	-$16.1M	–	550
2018 Q2	$16.1M	Sell	1,057,000 -4,076,000	-79%	-$72.7M	﹤0.01%	475
2018 Q1	$115M	Buy	5,133,000 +2,305,000	+82%	+$63.8M	0.03%	283
2017 Q4	$85.2M	Buy	2,828,000 +275,000	+11%	+$8.79M	0.02%	309
2017 Q3	$96.2M	Hold	2,553,000	–	–	0.02%	297
2017 Q2	$71.2M	Hold	2,553,000	–	–	0.02%	319
2017 Q1	$87.8M	Sell	2,553,000 -950,000	-27%	-$33.5M	0.02%	298
2016 Q4	$101M	Sell	3,503,000 -261,000	-7%	-$6.91M	0.03%	281
2016 Q3	$120M	Hold	3,764,000	–	–	0.03%	266
2016 Q2	$122M	Buy	3,764,000 +430,000	+13%	+$14.4M	0.03%	259
2016 Q1	$93.2M	Buy	3,334,000 +590,000	+22%	+$12.9M	0.03%	281
2015 Q4	$97.8M	Sell	2,744,000 -377,000	-12%	-$13.3M	0.03%	284
2015 Q3	$103M	Sell	3,121,000 -300,756	-9%	-$12.5M	0.03%	284
2015 Q2	$143M	Sell	3,421,756 -29,644	-0.9%	-$1.15M	0.04%	273
2015 Q1	$112M	Buy	3,451,400 +2,108,400	+157%	+$72.5M	0.03%	294
2014 Q4	$42.6M	Buy	1,343,000 +530,203	+65%	+$15M	0.01%	382
2014 Q3	$20.1M	Buy	812,797 +412,797	+103%	+$9.65M	0.01%	431
2014 Q2	$9.04M	Hold	400,000	–	–	﹤0.01%	485
2014 Q1	$9.73M	Buy	400,000 +150,000	+60%	+$3.79M	﹤0.01%	472
2013 Q4	$6.25M	Hold	250,000	–	–	﹤0.01%	469
2013 Q3	$6.87M	Buy	+250,000	New	+$5.23M	﹤0.01%	463